National Institute of Neurological Disorders and Stroke

North America, Maryland, United States, Bethesda

Description

National Institute of Neurological Disorders and Stroke is a Medical trial health authority.

Investor Profile

National Institute of Neurological Disorders and Stroke has made 56 investments, with 11 in the past 12 months and 75% as lead.

Stage Focus

Grant (100%)

Country Focus

United States (100%)

Industry Focus

Biotechnology
Health Care
Medical
Therapeutics
Pharmaceutical
Life Science
Medical Device
Health Diagnostics
Neuroscience
Biopharma

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does National Institute of Neurological Disorders and Stroke frequently co-invest with?

National Institutes of Health

North America, Maryland, United States, Bethesda

Co-Investments: 2

New York State Department of Health

North America, New York, United States, Albany

Co-Investments: 1

National Institute on Aging

North America, Maryland, United States, Bethesda

Co-Investments: 2

National Cancer Institute

North America, Maryland, United States, Bethesda

Co-Investments: 2

What are some of recent deals done by National Institute of Neurological Disorders and Stroke?

Feinstein Institute for Medical Research

Manhasset, New York, United States

Feinstein Institute for Medical Research focuses on clinical trials and publishing medical and scientific knowledge to cure diseases.

ConsultingHealth CareHealth DiagnosticsMedicalPublishing

GrantMar 20, 2025

Amount Raised: $3,000,000

The Feinstein Institutes

Ballston Lake, New York, United States

The Feinstein Institutes is a research services centre.

GrantMar 20, 2025

Amount Raised: $3,000,000

WideTrial

South San Francisco, California, United States

WideTrial is a third-party sponsor of group-level Expanded Access programs (EAPs).

BiotechnologyHealth Care

GrantNov 19, 2024

Amount Raised: $22,000,000

UTHealth Houston

Houston, Texas, United States

UTHealth Houston provides resources for health care education, innovation, and scientific discovery.

EducationHealth CareProfessional Services

GrantOct 9, 2024

Amount Raised: $2,500,000

MediciNova

San Diego, California, United States

MediciNova is a biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.

BiotechnologyPharmaceuticalTherapeutics

GrantSep 30, 2024

Amount Raised: $22,000,000

Mayo Clinic

Rochester, Minnesota, United States

MayoClinic is a nonprofit medical practice and medical research group focused on integrated health care, education, and research.

BiotechnologyHealth CareHospitalMedicalWellness

GrantSep 24, 2024

Amount Raised: $12,000,000

Fzata, Inc.

Halethorpe, Maryland, United States

Fzata's novel platform modality for oral biologics is Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates.

MedicalPharmaceutical

GrantSep 24, 2024

Endomimetics

Birmingham, Alabama, United States

Endomimetics is a developer of bio-nanometric coating technology.

BiopharmaBiotechnologyManufacturing

GrantSep 17, 2024

Amount Raised: $2,800,000

RevBio

Lowell, Massachusetts, United States

RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.

BiotechnologyHealth CareMedicalMedical Device

GrantSep 16, 2024

Amount Raised: $2,400,000

Neurexis Therapeutics

Aurora, Colorado, United States

Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.

BiotechnologyHealth CareLife ScienceMedicalNeuroscience

GrantSep 16, 2024

Amount Raised: $3,000,000

National Institute of Neurological Disorders and Stroke

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does National Institute of Neurological Disorders and Stroke frequently co-invest with?

What are some of recent deals done by National Institute of Neurological Disorders and Stroke?

Ready to Raise Capital?

Pages

Free tools